Arrowhead Pharmaceuticals Inc. buy Morgan Stanley
Start price
21.04.26
/
50%
€61.38
Target price
21.04.27
€84.90
Performance (%)
23.10%
Price
08:31
€75.56
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley currently has a performance of 23.10%. This prediction currently runs until 21.04.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 15.887% | 15.887% |
| iShares Core DAX® | 0.855% | 0.389% |
| iShares Nasdaq 100 | -0.989% | -4.400% |
| iShares Nikkei 225® | -1.781% | -11.216% |
| iShares S&P 500 | 0.057% | 0.778% |
Comments by Morgan_Stanley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (ARWR) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $100.00 price target on the stock, up from $78.00.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Morgan_Stanley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€76.32
23.07.26
23.07.26
€105.00
23.07.27
23.07.27
-1.00%
08:31
08:31
